Abstract
Breast cancer is the most common cancer in women, and its incidence has been steadily increasing over the past couple of decades. According to the American Cancer Society, the estimated risk of a woman developing breast cancer at some time in her life is now 1:9, almost double the risk observed in 1940, and breast cancer is the most common cause of cancer death among women in most Western countries. For many cancers, a patient surviving 5 years after primary treatment is considered cured. This is not so for breast cancer, where the risk of recurrence persists after 5 years of survival, although it is decreased.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag Berlin · Heidelberg
About this paper
Cite this paper
Neymark, N. (1998). Breast Cancer. In: Assessing the Economic Value of Anticancer Therapies. Recent Results in Cancer Research, vol 148. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-72123-6_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-72123-6_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-72125-0
Online ISBN: 978-3-642-72123-6
eBook Packages: Springer Book Archive